CIK 0001534248
- Non-accelerated filer
- Smaller reporting company
Chemomab Therapeutics Ltd.
Sign in to watch- Ticker
- CMMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- EIN
- 813676773
- Phone
- +972 773310156
- Business address
- KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,516
- in 1 filing
Net −$6,516. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-16 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.30 | $825 | 1,750 |
| 2022-03-16 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.25 | $813 | 2,000 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $4.00 | $1K | 250 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.98 | $995 | 500 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.90 | $975 | 1,000 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $4.10 | $1K | 1,250 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $4.20 | $1K | 1,500 |
| 2021-11-08 | Marvin Donald Executive VP, CFO & COO | Grant or award · Option to Purchase American Depositary Shares | +196,875 | 196,875 | ||
| 2021-11-08 | Marvin Donald Executive VP, CFO & COO | Grant or award · Option to Purchase American Depositary Shares | +196,875 | 196,875 |
Page 1 of 1 · 9 trades